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Impact of Right Ventricular Performance in Patients Undergoing
Extracorporeal Membrane Oxygenation Following Cardiac Surgery
Philipp E. Bartko, MD, PhD; Dominik Wiedemann, MD; Lore Schrutka, MD; Christina Binder, MD; Carlos G. Santos-Gallego, MD;
Andreas Zuckermann, MD; Barbara Steinlechner, MD; Herbert Koinig, MD, MBA; Gottfried Heinz, MD; Alexander Niessner, MD, MSc;
Daniel Zimpfer, MD; G€unther Laufer, MD; Irene M. Lang, MD; Klaus Distelmaier, MD, PhD; Georg Goliasch, MD, PhD
Background-—Extracorporeal membrane oxygenation following cardiac surgery safeguards end-organ oxygenation but unfavorably
alters cardiac hemodynamics. Along with the detrimental effects of cardiac surgery to the right heart, this might impact outcome,
particularly in patients with preexisting right ventricular (RV) dysfunction. We sought to determine the prognostic impact of RV
function and to improve established risk-prediction models in this vulnerable patient cohort.
Methods and Results-—Of 240 patients undergoing extracorporeal membrane oxygenation support following cardiac surgery,
111 had echocardiographic examinations at our institution before implantation of extracorporeal membrane oxygenation and
were thus included. Median age was 67 years (interquartile range 60-74), and 74 patients were male. During a median follow-
up of 27 months (interquartile range 16-63), 75 patients died. Fifty-one patients died within 30 days, 75 during long-term
follow-up (median follow-up 27 months, minimum 5 months, maximum 125 months). Metrics of RV function were the
strongest predictors of outcome, even stronger than left ventricular function (P<0.001 for receiver operating characteristics
comparisons). Speciﬁcally, RV free-wall strain was a powerful predictor univariately and after adjustment for clinical variables,
Simpliﬁed Acute Physiology Score-3, tricuspid regurgitation, surgery type and duration with adjusted hazard ratios of 0.41
(95%CI 0.24-0.68; P=0.001) for 30-day mortality and 0.48 (95%CI 0.33-0.71; P<0.001) for long-term mortality for a 1-SD
(SD=6%) change in RV free-wall strain. Combined assessment of the additive EuroSCORE and RV free-wall strain improved
risk classiﬁcation by a net reclassiﬁcation improvement of 57% for 30-day mortality (P=0.01) and 56% for long-term mortality
(P=0.02) compared with the additive EuroSCORE alone.
Conclusions-—RV function is strongly linked to mortality, even after adjustment for baseline variables and clinical risk scores. RV
performance improves established risk prediction models for short- and long-term mortality. ( J Am Heart Assoc. 2017;6:
e005455. DOI: 10.1161/JAHA.116.005455.)
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E xtracorporeal membrane oxygenation (ECMO) is a life-saving method for critically ill patients following cardio-
vascular surgery.1 Despite growing evidence supporting the
use of ECMO therapy,2-4 outcome remains poor, and accurate
risk stratiﬁcation challenging: successful weaning probabili-
ties are as low as 31% depending on the series, and in-
hospital fatal events are frequent, resulting in short-term
mortalities of up to 84%.3,5-13 Prior studies have focused on
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clinical variables, comorbidities, and renal function for risk
stratiﬁcation before ECMO initiation.1-3,9,10,14-17 However,
data on cardiac physiology and myocardial mechanics before
therapy—easily assessable by echocardiography—and their
predictive value are scarce.
Pre-, and postcardiotomy right ventricular (RV) dysfunction
is strongly linked to outcome.18-22 The etiology of RV failure is
multifactorial: pericardiotomy results in loss of pericardial
support and a decline of myocardial blood ﬂow.23,24 Car-
diopulmonary bypass itself may cause an inﬂammatory
response.25 Furthermore, ECMO initiation results in rising
afterload increasing left ventricular (LV) end-diastolic pressure
and consequently RV pressure load.20,26-28 In the absence of
preexisting RV dysfunction, the compensatory reserve is
sufﬁcient to outbalance those stressors, resulting in a low
incidence of postoperative right heart failure.29 In patients
requiring mechanical circulatory support the compensatory
reserve might be exhausted, and the alteration of the
hemodynamic load opposed to the heart might set in
counterproductively. Metrics of RV function are powerful
predictors of outcome in patients with pulmonary hyperten-
sion, valvular heart disease, patients undergoing cardiac
surgery19,30-32 as well as patients receiving LV assist
devices.33,34 Complemental imaging techniques such as
speckle-tracking imaging allow detection of even subclinical
changes of myocardial function and are readily available.
Recent studies suggest that speckle tracking of strain more
accurately quantiﬁes RV function as opposed to traditional
metrics and improves risk stratiﬁcation.35,36
We therefore set out to investigate the prognostic
signiﬁcance of preoperative right heart function assessed by
standard echocardiography and speckle-tracking strain imag-
ing, a novel method better reﬂecting myocardial mechanics.
Furthermore, we aimed to reﬁne established risk-prediction
models by implementation of RV function.
Methods
Study Population
Between September 2003 and June 2014, adult patients
undergoing venoarterial ECMO therapy after cardiovascular
surgery were enrolled in our registry. All patients were
recruited at the Vienna General Hospital, a university-afﬁliated
tertiary care center. The study was approved by the Ethics
Committee of the Medical University of Vienna and is in line
with the Declaration of Helsinki. All patients admitted to the
Medical University of Vienna provided written consent at
hospital admission. For the echocardiographic analysis only
patients who underwent a comprehensive preoperative
echocardiographic exam at our institution were selected.
Patients undergoing a heart transplant were excluded from
further analysis (Figure S1).
Echocardiographic Assessment
Standard echocardiograms were performed using commer-
cially available equipment (Vivid 7 and Vivid 9, GE Healthcare,
Chicago, IL; Acuson Sequoia, Siemens, Berlin, Germany).
Cardiac morphology was assessed using diameters and areas
as well as volumetric measurements in standard 4- and 2-
chamber views.37
LV volumes and ejection fraction (EF) were calculated
using the biplane Simpson method. RV function was quanti-
ﬁed by fractional area change, tricuspid annular peak systolic
excursion (TAPSE), and RV longitudinal free-wall strain
(RVLS).37,38 Right-to-left ventricle diameter ratio and RV
contraction pressure index were calculated as previously
reported.39,40 Semiquantitative assessment of right heart
function was performed by experienced readers using multiple
acoustic windows and graded as normal, mild, mild to
moderate, moderate, moderate to severe, and severe. Valve
stenosis and regurgitation were quantiﬁed using an integrated
approach and graded as none, mild, mild to moderate,
moderate, moderate to severe, and severe according to
current guidelines.41,42 Systolic pulmonary artery pressures
were calculated by adding the peak tricuspid regurgitation
(TR) systolic gradient to the estimated central venous
pressure.
Left- and Right-Ventricular Longitudinal Strain
LV and RV longitudinal shortening (strain) were measured by
tracking the displacement of speckles from 2-dimensional
images using an automated algorithm (Speckle tracking).43,44
Longitudinal strain is the percentage shortening of a region of
interest relative to its original length.45 This method has been
previously shown to provide angle independent and objective
quantiﬁcation of myocardial systolic mechanics.37,38 LV and
Clinical Perspective
What Is New?
• Right ventricular function is a powerful predictor of mortality
and improves risk stratiﬁcation in patients who need veno-
arterial extracorporeal membrane oxygenation after cardio-
vascular surgery.
What Are the Clinical Implications?
• Although left ventricular function might have only minor
impact on outcome, prognosis seems limited if right
ventricular performance is already affected preoperatively.
• Further studies are needed to test whether the dismal
course can be improved by therapies tailored speciﬁcally to
the failing right heart.
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RV strain were measured using commercially available
software (2D Cardiac Performance Analysis; TomTec Imaging
Systems, Munich, Germany) that allows standardized quan-
tiﬁcation of myocardial strain within 1 platform independently
of the echo machine vendor. Files with poor frame rates
(<40 fps) and inadequate image quality were excluded from
the analyses. Left ventricular longitudinal strain was calcu-
lated in standard 4-, 2-, and 3-chamber views as described
previously.43 RVLS strain was assessed in a standard 4-
chamber view as described previously.44 Strain data are
expressed as the percentage of systolic shortening, where
negative longitudinal deformation corresponds to shortening
(contraction) during systole.
ECMO Management
Venoarterial ECMO support was initiated in patients with
systolic arterial hypotension (<80 mm Hg) or other clinical
signs of cardiogenic shock, end-organ failure, or anaerobic
metabolism despite optimized supportive therapeutic mea-
sures (ﬂuid, inotropes, intra-aortic balloon pump). The ECMO
system consisted of a pump console (Bio-Console560,
Medtronic, Fridley, MN; or Cardiohelp system, Maquet,
Germany) and an inline plasma-tight hollow-ﬁber microporous
membrane oxygenator (Afﬁnity-NTTM, Medtronic, Fridley, MN;
or HLS module advanced, Maquet, Germany). All parts of the
system were routinely checked every 24 hours by the on-shift
intensive care physician or an experienced perfusionist. The
complete system was coated with heparin to prevent clotting.
If any signs of ﬁbrin deposits or blood clots were present or if
blood oxygenation levels declined drastically, the circuit was
changed. Ventilator settings were adapted to ensure lung-
protective ventilation with peak airway pressures below
25 cm H2O and respiratory tidal volumes between 6 and
8 mL/kg. The fraction of inspired oxygen on the oxygenator
was adjusted to maintain a target partial pressure of oxygen
of 80 to 100 mm Hg.
Clinical Deﬁnitions and End Points
The Simpliﬁed Acute Physiology Score-3 was recorded; and
the European System of Cardiac Operative Risk Evaluation
(EuroSCORE) was assessed in every patient at intensive
care unit admission. All-cause 30-day mortality was
selected as primary end point, and all-cause long-term
mortality was deﬁned as death occurring throughout the
entire follow-up duration of a median of 27 months
(minimum 5 months, maximum 125 months) as a sec-
ondary end point. Mortality data were obtained by screen-
ing the national registry of deaths including screening for
the cause of death (according to the International Classi-
ﬁcation of Diseases, 10th Revision).
Statistical Methods
Discrete data were presented as count and percentage and
analyzed by using chi-squared tests. Continuous data were
presented as median and interquartile range (IQR) and
compared using Kruskal-Wallis tests. Cox proportional hazard
regression analysis was applied to assess the effect of the
respective echocardiographic parameters on survival. Results
were expressed as the hazard ratio (HR) for a 1-SD change
with the respective 95%CIs. To account for potential con-
founders, we adjusted for age, sex, Simpliﬁed Acute Physiol-
ogy Score-3, TR, type of cardiovascular surgery, and
procedure duration. Statistical signiﬁcance was given if 2-
sided P<0.05. Kaplan-Meier analysis was applied to evaluate
the effect of RV free-wall strain and TAPSE on survival and
compared them using a log-rank test. The respective variables
were divided into 2 groups using the median of the respective
variable as a cutoff value. The discriminatory power of the
respective variables was assessed using receiver operating
characteristic analysis and Harrell C-statistic. Receiver oper-
ating characteristic analysis was used to assess the predictive
accuracy of the parameters to predict short- and long-term
survival. An improvement in individual risk prediction was
examined by the net reclassiﬁcation improvement. Intraob-
server, and interobserver variability for RVLS and TAPSE were
assessed in 20 randomly selected patients. Interobserver
agreement and intraobserver consistency were presented by
using interclass correlation coefﬁcients and a 95%CI. All
statistical analyses were computed using the STATA11
software package and SPSS 23.
Results
General Characteristics
Between September 2003 and June 2014, we included 240
consecutive patients undergoing venoarterial ECMO support
following cardiovascular surgery as previously described.14-16
Of these, 51 patients underwent cardiac transplantation and
were therefore not eligible for study inclusion. A total of 111
patients had preoperative echocardiographic exams at our
institution before ECMO therapy and were therefore included
in our analysis (Figure S1). The median EuroSCORE of the
echocardiographic study population was 11 points (8-13), and
the median age was 67 years (IQR 60-74), respectively.
Detailed baseline characteristics for the entire study popula-
tion as well as the echocardiographic study population are
displayed in Table 1. Valve surgery was performed in 44 (40%)
patients, coronary artery bypass graft surgery in 14 (13%),
combined coronary artery bypass graft and valve surgery in
36 (32%), ventricular assist device implantation in 8 (7%),
aortic reconstruction in 3 (3%), and other cardiovascular
surgeries in 6 (5%) patients. Patients undergoing isolated
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valve procedures had single-valve procedures done in 52%, 2-
valve procedures in 32%, and 3-valve procedures in 16% of the
cases. In patients undergoing valve and CABG, single-valve
procedures were done in 69%, 2-valve procedures in 22%, and
3-valve procedures in 8% of the cases. ECMO cannulation was
femoral (arterial)-femoral (venous) in 47% of patients, subcla-
vian (arterial)-femoral (venous) in 39% of patients, and central
(arterial)-femoral (venous) in 14% of patients. ECMO support
was initiated due to weaning failure from cardiopulmonary
bypass (60%), immediate postoperative cardiogenic shock in
the operating room (26%), postoperative bleeding/tamponade
with cardiogenic shock (7%), immediate postoperative respi-
ratory failure in the operating room (3%), and miscellaneous
conditions (4%). Of the 111 patients included in this analysis,
95 (86%) were (primarily) successfully weaned from VA-ECMO,
and 16 (14%) died on VA-ECMO support. Fifty-one (46%)
patients died within 30 days after VA-ECMO implantation, and
75 (68%) during long-term follow-up.
Table 1. Baseline Characteristics of the Total ECMO Study Population (n=240) and the Echocardiographic Substudy Population
(n=111)
Baseline Characteristics at Hospital Admission
Total Study
(n=240)
Echocardiographic Study
Population (n=111)
Age, y (IQR) 65 (55-72) 67 (60-74)
Body-mass index, n (IQR) 27 (24-30) 27 (24-31)
Male sex, n (%) 172 (72) 74 (67)
EuroSCORE (additive), points (IQR) 10 (8-13) 11 (8-13)
Procedure duration, h (IQR) 8.0 (6.1-9.4) 7.2 (5.3-9.3)
Hypertension, n (%) 169 (70) 83 (75)
Diabetes mellitus, n (%) 66 (28) 37 (33)
Hypercholesterolemia, n (%) 125 (52) 60 (54)
Coronary artery disease, n (%) 124 (52) 58 (52)
Glucose, mg/dL (IQR) 109 (92-142) 112 (93-148)
Total cholesterol, mg/dL (IQR) 143 (104-182) 146 (105-182)
Triglycerides, mg/dL (IQR) 109 (81-156) 111 (74-172)
Creatinine, mg/dL (IQR) 1.3 (1.1-1.8) 1.3 (1.0-1.9)
Estimated GFR, mL/min per 1.73 m2 (IQR) 51 (39-69) 49 (36-70)
Total bilirubin, mg/dL (IQR) 1.1 (0.6-1.6) 0.9 (0.6-1.4)
ASAT, U/L (IQR) 33 (23-67) 34 (25-56)
ALAT, U/L (IQR) 33 (23-67) 26 (18-40)
c-GT, U/L (IQR) 54 (32-105) 54 (29-102)
Hemoglobin, mg/dL (IQR) 12.0 (10.1-13.6) 11.2 (9.9-13.0)
Platelets, 1000/lL (IQR) 188 (134-241) 186 (136-243)
C-reactive protein, mg/dL (IQR) 1.0 (0.3-4.3) 1.3 (0.3-7.6)
Leukocytes, 1000/lL (IQR) 8.0 (6.1-11.1) 8.2 (6.0-12.1)
Post-ECMO implantation (first 24 h)
SAPS-3 at ICU admission, n (%) 43 (36-51) 43 (36-51)
ECMO flow, L/min (IQR) 3.4 (2.5-4.3) 3.0 (2.5-4.0)
ECMO rotation, rpm (IQR) 3000 (2485-3500) 2740 (2270-3420)
ECMO gas flow, L/min (IQR) 2.5 (2.0-3.0) 2.0 (2.0-3.0)
ECMO FiO2, % (IQR) 70 (60-100) 68 (60-80)
ECMO duration, median days (IQR) 4 (3-7) 5 (2-7)
Counts are given as numbers and percentages. Continuous variables are given as median and interquartile range. ALAT indicates alanine aminotransferase; ASAT, aspartate
aminotransferase; ECMO, extracorporeal membrane oxygenation; FiO2, fraction of inspired oxygen; GFR, glomerular ﬁltration rate; c-GT, c-glutamyl transferase; IQR, interquartile
range; SAPS-3, simpliﬁed acute physiology score 3.
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Preoperative Echocardiographic Assessment of
the RV
Median RV diameter measured 35 mm (IQR 30-42 mm), and
the RV end-diastolic area was 19 cm2 (IQR 14-24 cm2). The
median systolic pulmonary pressure was estimated as
56 mm Hg (IQR 41-64 mm Hg). RV function was assessed
semiquantitatively and using TAPSE (15 mm, IQR 11-18 mm),
fractional area change (35%, IQR 27% to 42%), and RV free-
wall strain (14%, IQR 11% to 20%). Detailed results of the
echocardiographic subanalysis are presented in Table 2. RV
free-wall strain demonstrated good reproducibility with an
interclass correlation coefﬁcient for intraobserver variability of
0.98 (95%CI 0.95-0.99) and for interobserver variability of
0.98 (95%CI 0.94-0.99). Comparable results were observed
for TAPSE (intraobserver 0.98, 95%CI 0.95-0.99; interobserver
0.97, 95%CI 0.93-0.99).
RV Function and Outcome
During a median follow-up time of 27 months (IQR 16-
63 months), 75 patients (68%) died. RV function assessed
semiquantitatively by TAPSE and by RVLS were signiﬁcantly
associated with 30-day as well as long-termmortality (Tables 3
and 4). The strongest association was found for RVLS with a
crude HR of 0.44 (95%CI 0.30-0.66; P<0.001) for 30-day
mortality and of a HR of 0.50 (95%CI 0.36-0.69; P<0.001) for
long-term mortality. The area under the curve (AUC) for 30-day
mortality was 0.76 for RV free-wall strain, 0.75 for TAPSE, and
0.73 for semiquantitative assessment of RV function and
remained persistent for long-term mortality with AUCs of 0.74,
0.72, and 0.68, respectively. AUCs for RV free-wall strain
indicated signiﬁcantly stronger risk prediction for 30-day and
long-term mortality compared with metrics of LV function
(P<0.001 for RV free-wall strain AUCs and LV ejection fraction
(LVEF) for both 30-day and long-term mortality, P<0.001 for RV
free-wall strain AUCs and left ventricular GLS (global long-
itudinal strain) for 30-day mortality and P<0.01 for long-term
mortality). The effect was even more pronounced after
multivariate adjustment with an adjusted HR of 0.41 (95%CI
0.24-0.68; P=0.001) for 30-day mortality and of a HR of 0.48
(95%CI 0.33-0.71; P<0.001) for long-term mortality. Kaplan-
Meier analysis conﬁrmed a signiﬁcant increase of mortality
with decreasing RVLS (30-day P=0.001; Figure Panel A; long-
term P=0.001) and decreasing TAPSE (30-day P<0.001; Figure
Panel B; long-term P<0.001). No association between mortality
and parameters of LV function including LV longitudinal strain
were observed (Tables 3 and 4).
RV Free-Wall Longitudinal Strain and Risk
Prediction
Combined assessment of the additive EuroSCORE and RV
free-wall strain led to a substantial improvement of the
discriminatory power measured by the Harrel C-statistic of the
EuroSCORE for 30-day mortality (EuroSCORE: 0.59 versus
EuroSCORE and RV free-wall strain 0.71; P=0.03) and for
long-term mortality (EuroSCORE: 0.59 versus EuroSCORE +
Table 2. Echocardiographic Characteristics of the Substudy
Population (n=111)
Echocardiographic
Study Population (n=111)
Left atrial/ventricular parameters
LA diameter, mm (IQR) 60 (55-68)
IVS thickness, mm (IQR) 14 (12-16)
LVEDD, mm (IQR) 46 (43-54)
LVEDV, mL (IQR) 125 (84-161)
LVESV, mL (IQR) 58 (38-95)
EF, % (IQR) 48 (37-55)
LV function (semiquantitative)
Moderately reduced, n (%) 10 (9)
Severely reduced, n (%) 18 (16)
LV global longitudinal strain, % (IQR) 12 (9 to 15)
Aortic stenosis (≥moderate), n (%) 31 (28)
Aortic regurgitation (≥moderate), n (%) 19 (15)
Mitral stenosis (≥moderate), n (%) 7 (5)
Mitral regurgitation (≥moderate), n (%) 51 (40)
Right atrial/ventricular parameters
RA diameter, mm (IQR) 58 (52-67)
RVEDD, mm (IQR) 35 (30-42)
RVEDA, cm2 (IQR) 19 (14-24)
RVSA, cm2 (IQR) 12 (9-16)
RV-LV diameter ratio, n (IQR) 0.71 (0.64-0.81)
RVCPI, mm9mm Hg (IQR) 501 (348-700)
FAC, % (IQR) 35 (27-42)
RV function (semiquantitative)
Moderately reduced, n (%) 28 (25)
Severely reduced, n (%) 17 (15)
TAPSE, mm (IQR) 15 (11-18)
RV free-wall longitudinal strain, % (IQR) 14 (11 to 20)
sPAP, mm Hg (IQR) 56 (41-64)
Tricuspid regurgitation (≥moderate), n (%) 43 (39)
FAC indicates fractional area change; IQR, interquartile range; IVS, interventricular
septum; LA, left atrium; LV, left ventricle; LVEDD, left ventricular end-diastolic diameter;
LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction;
LVESV, left ventricular end-systolic volume; RA, right atrium; RV, right ventricular; RVCPI,
right ventricular contraction pressure index; RVEDA, right ventricle end-diastolic area;
RVEDD, right ventricular end-diastolic diameter; RVSA, right ventricular systolic area;
sPAP, systolic pulmonary artery pressure; TAPSE, tricuspid annular plane systolic
excursion.
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RV free-wall strain 0.70; P=0.03). Simultaneous Cox propor-
tional hazards model yielded a crude HR of 0.46 (95%CI 0.31-
0.69, P<0.001; adjusted HR 0.42, 95%CI 0.25-0.69, P=0.001)
for RV-free-wall strain and a crude HR of 1.06 (95%CI 0.74-
1.53, P=0.75; adjusted HR 0.79, 95%CI 0.44-1.42, P=0.43) for
the EuroSCORE for 30-day mortality. For long-term mortality,
we observed a crude HR of 0.51 (95%CI 0.36-0.71, P<0.001;
adjusted HR 0.48, 95%CI 0.33-0.71, P<0.001) for RV-free-wall
strain and a HR of 1.19 (95%CI 0.90-1.57, P=0.23; adjusted
HR 0.90, 95%CI 0.59-1.36, P=0.61) for the EuroSCORE for
Table 3. Univariable Cox Proportional Hazard Model of Preoperative Echocardiographic Parameters
SD
30-Day Mortality Long-Term Mortality
HR (95%CI) P Value AUC HR (95%CI) P Value AUC
LVEDV, mL 57 0.84 (0.59-1.20) 0.34 0.59 0.88 (0.66-1.17) 0.37 0.55
LV function  0.84 (0.67-1.05) 0.13 0.59 0.92 (0.77-1.11) 0.40 0.52
EF, % 13 1.37 (0.98-1.92) 0.06 0.60 1.19 (0.92-1.55) 0.19 0.55
LV global longitudinal strain, % 5 1.21 (0.88-1.66) 0.25 0.61 1.01 (0.81-1.40) 0.64 0.51
RVEDA, cm2 9 0.88 (0.60-1.28) 0.50 0.54 0.88 (0.66-1.18) 0.39 0.55
RV-LV diameter ratio, n (IQR) 0.23 1.01 (0.82-1.39) 0.63 0.55 0.78 (0.49-1.25) 0.31 0.53
RVCPI, mm9mm Hg (IQR) 310 0.78 (0.49-1.25) 0.31 0.60 0.76 (0.53-1.10) 0.16 0.56
FAC, % 10 0.77 (0.53-1.10) 0.15 0.60 0.82 (0.61-1.10) 0.18 0.57
RV function  1.60 (1.25-2.04) <0.001 0.73 1.49 (1.22-1.83) <0.001 0.68
TAPSE, mm 5 0.51 (0.35-0.73) <0.001 0.75 0.54 (0.40-0.72) <0.001 0.72
RV free-wall strain, % 6 0.44 (0.30-0.66) <0.001 0.76 0.50 (0.36-0.69) <0.001 0.74
sPAP, mm Hg 19 1.27 (0.94-1.72) 0.12 0.59 1.27 (0.97-1.68) 0.09 0.64
Hazard ratios (HR) refer to a 1-SD increase/decrease in continuous variables and to a reduction in 1 category of left ventricular/right ventricular function. Additionally, receiver operating
characteristics for the respective values are presented. AUC indicates area under the curve; EF, left ventricular ejection fraction; FAC, fractional area change; IQR, interquartile range; LV,
left ventricular; LVEDV, left ventricular end-diastolic diameter; RV, right ventricular function; RVCPI, right ventricular contraction pressure index; RVEDA, right-ventricular end-diastolic area;
sPAP, estimated systolic pulmonary artery pressure; TAPSE, tricuspid annular plane systolic excursion.
Table 4. Multivariate Cox Proportional Hazard Model of Preoperative Echocardiographic Parameters
SD
30-Day Mortality Long-Term Mortality
Adjusted HR (95%CI) P Value Adjusted HR (95%CI) P Value
LVEDV, mL 57 1.09 (0.68-1.74) 0.74 0.72 (0.63-1.37) 0.93
LV function  0.80 (0.58-1.12) 0.17 0.81 (0.62-1.04) 0.10
EF, % 13 1.58 (0.98-2.55) 0.06 1.35 (0.92-1.98) 0.13
LV global longitudinal strain, % 5 1.44 (0.87-2.39) 0.16 1.24 (0.82-1.87) 0.31
RVEDA, cm2 9 0.93 (0.79-0.93) 0.79 0.84 (0.57-1.25) 0.82
RV-LV diameter ratio, n (IQR) 0.23 1.02 (0.75-1.02) 0.89 1.29 (0.43-3.81) 0.65
RVCPI, mm9mm Hg (IQR) 310 0.96 (0.55-1.57) 0.87 0.82 (0.55-1.23) 0.34
FAC, % 10 0.85 (0.55-1.31) 0.46 0.56 (0.62-1.30) 0.56
RV function  1.51 (1.21-2.03) 0.007 1.64 (1.26-2.13) <0.001
TAPSE, mm 5 0.56 (0.36-0.86) 0.008 0.51 (0.34-0.75) 0.001
RV free-wall longitudinal strain, % 6 0.41 (0.24-0.68) 0.001 0.48 (0.33-0.71) <0.001
sPAP, mm Hg 19 1.25 (0.86-1.81) 0.25 1.20 (0.89-1.68) 0.29
Hazard ratios (HR) refer to a 1-SD increase/decrease in continuous variables and to a reduction in 1 category of left ventricular/right ventricular function. HRs are adjusted for all variables
in the clinical confounder model, ie, age, sex, SAPS-3 score, tricuspid regurgitation, type of cardiovascular surgery, and procedure duration. EF indicates left ventricular ejection fraction;
FAC, fractional area change; IQR, interquartile range; LV, left ventricular; LVEDV, left ventricular end-diastolic diameter; RV, right ventricular function; RVCPI, right ventricular contraction
pressure index; RVEDA, right-ventricular end-diastolic area; SAPS-3, simpliﬁed acute physiology score-3; sPAP, estimated systolic pulmonary artery pressure; TAPSE, tricuspid annular
plane systolic excursion.
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long-term mortality. Furthermore, an improvement in individ-
ual risk stratiﬁcation with combined assessment of the
additive EuroSCORE and RV free-wall strain with a net
reclassiﬁcation improvement of 57% for 30-day mortality
(P=0.01) and 56% for long-term mortality (P=0.02) were
observed.
Discussion
In this study we show the vital importance of RV function in
patients undergoing ECMO support following cardiovascular
surgery. Metrics of RV function are strong predictors of short-
term and long-term mortality in this vulnerable patient
population. These strong associations persist even after
adjustment for baseline clinical variables, surgical or ICU
admission scores, and careful consideration of confounders,
eg, severity of TR and type of surgery. Furthermore,
surrogates of RV function improve established risk prediction
models reﬂected by a substantial improvement of the
discriminatory power and individual risk stratiﬁcation for both
short-term and long-term mortality.
Prognostic Value of LV Morphology and Function
The prognostic importance of LVEF before cardiac surgical
procedures has been shown in several studies for a variety of
cardiac diseases and has therefore been incorporated in risk
stratiﬁcation tools such as the EuroSCORE.46 Thus, several
studies have investigated the impact of LV function before
ECMO initiation on outcome. Most recently only 117 out of 4
studies2,8,9 that investigated EF before postcardiotomy ECMO
initiation found a signiﬁcant difference in EF between
survivors and nonsurvivors. Interestingly, in this study, the
predominant surgical procedure before ECMO initiation was
isolated coronary artery bypass graft surgery as opposed to
others where valve procedures were more prevalent. A major
limitation of EF is the diversity of pathologies that inﬂuence
this parameter. It grossly underestimates the extent of
myocardial impairment, particularly in patients with concomi-
tant left-sided regurgitant valve lesions. Indeed, for a given
contractility a signiﬁcantly increased preload and reduced
afterload (a common ﬁnding in mitral and aortic regurgitation)
will yield a normal-appearing EF despite intrinsic myocardial
damage, dysfunction, and reduced output.47,48 The hetero-
geneity of the cohort in the present and other studies
therefore makes it almost impossible to predict outcomes by
preoperative EFs. Furthermore, the sample size in the study
by Hsu et al was relatively small (n=51), and the regression
analysis was adjusted only for the chronic heart failure stage
and preoperative hypotension. Rastan and co-workers also
detected no difference in EF between survivors and nonsur-
vivors in a large cohort (n=517) of patients who were in need
of ECMO after cardiac surgery.2 Other contemporary studies
that investigated precardiotomy EF as a predictor of outcome
were underpowered and lacked multivariable regression
analyses.8,9,17 A probable limitation of the EF is its operator
dependency and mistakes due to endocardial delineation
errors. We therefore also investigated a new index of LV
function—peak systolic LV strain—measured by an auto-
mated speckle-tracking algorithm, which previously has been
shown to be a more sensitive marker of intrinsic myocardial
dysfunction, albeit subject to similar limitations as EF such as
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Figure. Kaplan-Meier estimates of 30-day mortality according to right ventricular (RV) free-wall strain (A, P=0.001) and tricuspid annular plane
systolic excursion (TAPSE) (B, P<0.001).
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load dependence.43,49 Accordingly, we also found the LV
longitudinal strain to be an insigniﬁcant predictor of outcome
in this subset of patients. Venoarterial ECMO support
ultimately is an intervention to maintain end-organ perfusion,
and the ECMO initiation should not be withheld from patients
based on preoperative LV dysfunction.
Prognostic Value of RV Function
RV function may be impaired in a variety of cardiovascular and
pulmonary disease states with chronic left-sided heart failure
being the most common.50,51 Both pathophysiological and
prognostic signiﬁcance of the right heart and pulmonary
circulation have been underestimated in the past but more
recently have been recognized to be of crucial prognostic
signiﬁcance.52 The same is true in postcardiotomy ECMO
support: although preoperative LV function has been studied
extensively, the role of RV function and pulmonary circulation
remains unknown. The incidence of right heart failure
following cardiotomy is relatively low, ranging from 0.04% to
1% depending on the study.29 However, with more heteroge-
neous cohorts, a relative increase can be observed. In
particular, recipients of LV assist devices are susceptible to
refractory right heart failure, which occurs in up to 30%.29
Similar hemodynamic concepts apply to patients receiving
ECMO support after pericardiotomy: altered interventricular
balance introduces a hemodynamic load shift toward the
pulmonary circulation and the right heart. We show—for the
ﬁrst time—a high incidence of RV impairment in this
vulnerable patient cohort and its prognostic signiﬁcance. Of
note, metrics of RV function were strong predictors of
outcome, univariate and after comprehensive adjustment for
clinical variables and confounders. The major advantage of RV
strain and TAPSE, as opposed to fractional area change is that
they purely reﬂect the RV function without integrating the
interventricular septum. Furthermore, there is less likelihood
of endocardial delineation error, a common source of error in
volumetric or area measurements. Anatomic features, eg,
prominent trabeculation of the right heart, add complexity to
endocardial border delineation. TAPSE is a powerful, fast, and
easily obtainable measurement. However, a major limitation
of this measure is that it is obtained at only 1 single region of
interest—the lateral tricuspid annulus. In contrast, RV strain
tracks speckles throughout the entire lateral wall of the right
heart, reﬂecting more speciﬁcally the myocardial ﬁber
contractility. Our results suggest that ideally RVLS should
be used to predict outcome and improve currently established
risk prediction model scores. However, given the limitations of
nonavailability of speckle-tracking software in some hospitals
and the lack of standardization between vendors, alternative
surrogate markers of RV function such as TAPSE, semiquan-
titative assessment by an experienced reader, or an
integrated approach seem to be valid alternatives to estimate
RV function and enhance risk stratiﬁcation.
We also investigated more experimental metrics of RV
function that have shown to be predictive in mechanical
circulatory support patients. We calculated the RV contraction
pressure index as a surrogate for the RV stroke-work index
and the RV to LV diameter ratio. Those parameters were not
signiﬁcantly predictive of outcome. The major limitations of
the calculated values are their susceptibility to measurement
errors. Ratios introduce an additional possible error by
combining 1 or more measurements. This might particularly
bias the RV to LV diameter ratio as well as area measure-
ments of the right heart. The right heart is a complex 3-
dimensional structure, and a single diameter might not
adequately reﬂect the size. The estimated pulmonary pres-
sures from the tricuspid regurgitation velocities that are
incorporated into the RV contraction pressure index to
estimate RV stroke-work index might bias this particular
measurement because they are dependent on right heart
function and on the gradient between the RV and the right
atrium, which might lead to gross underestimations of systolic
pulmonary pressures and hence bias of the calculated
measurements.
The presence of TR may mask reduced RV function just as
mitral regurgitation may mask reduced LV performance.
Indeed, signiﬁcant TR was highly prevalent in this series (TR
≥moderate in 39% of the patients). Kammerlander and co-
workers recently proved that there was no signiﬁcant
association between TR and outcome in a prospective cohort
late after left-sided heart valve surgery and pointed out the
prognostic importance of RV function.53 Similarly, in the
present study, TR is rather a consequence of RV dysfunction
and increased afterload than the primary culprit.
In this series we show the crucial role of RV function in
patients receiving ECMO support after pericardiotomy. Our
data indicate that patients in need of ECMO after pericar-
diotomy have a limited prognosis if RV function is already
impaired preoperatively. Whether the dismal clinical course
can be altered by speciﬁc interventions remains to be
demonstrated. Potential strategies to alleviate the impact of
reduced RV function on outcome might include (1) avoiding
open heart surgery—eg, showing a preference for minimally
invasive/transcatheter approaches; (2) optimizing inotropic
treatment54; (3) use of pulmonary vasodilators; (4) early use
of biventricular assist devices; and (5) prompt evaluation of
candidates for high-urgency heart transplant.
Strengths and Limitations
Echocardiographic data were available for only a relatively
small subset of patients. However, there were no signiﬁcant
differences in baseline characteristics between patients who
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underwent comprehensive exams at our institution before
ECMO therapy and those with extramural reports, and so far,
this is the ﬁrst study with thorough analyses of biventricular
morphology and function in patients subsequently receiving
ECMO support. Although comparable mortality rates suggest
similar morbidity, we cannot rule out some degree of selection
bias. There is always an element of inter- and intraobserver
variability, but we demonstrate it to be within an acceptable
range given the presence of experienced readers.
Conclusions
In this series of patients on ECMO support, RV function before
cardiac surgery is a strong and independent predictor of both
short-term and long-term mortality. The results suggest that
RV function assessed by echocardiography improves the
predictive power of the currently used risk prediction models.
Finally, peak systolic strain of the lateral RV free-wall might
best reﬂect intrinsic RV contractile ﬁber dysfunction, but
TAPSE or semiquantitative assessment by experienced read-
ers might be valid alternatives if speckle-tracking software is
not available. Further studies are needed to assess the
possible treatment strategies to support the right heart in
patients in need of ECMO support.
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SUPPLEMENTAL MATERIAL 
Figure S1. Flow diagram. Of 240 patients who received a VA-ECMO after cardiotomy at the 
Vienna General Hospital, 56 were excluded because they underwent cardiac transplantation. In the 
remaining cohort of 189 patients echo images were available in 111 patients.  
 
 
